Screening fOR Throat Cancer
Key facts
- Who runs it
- Johns Hopkins University
- Where
- Baltimore, United StatesSee the site
- Trial code
- Status
- Not yet recruiting
- People taking part
- 2,500 people, planned
- Starts
- Jan 2027
- Expected to end
- Jan 2037
- Type of study
- Observational
- Record updated
- 17 November 2026
Who can take part
- Age
- 40 years to 69 years
- Sex
- Men only
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 16 criteriaShow less
Who can take part
- Part I: Participants in Screening; To be eligible to participate in Part I of this study, an individual must meet the following criteria:; Community and Internet Screen eligibility:
- Male, 40-69 years old
- Willing to self-collect or come in person to collect screening biospecimens
- Willing to be contacted to arrange follow-up visits, if determined to be eligible for follow-up
- Ability to understand and the willingness to sign a written informed consent document; Biorepository Screen eligibility:
- Male, 40-69 years old
- Active participant within MWCCS
- Willing to be contacted to arrange follow-up visits, if determined to be eligible for follow-up
- Ability to understand and the willingness to sign a written informed consent document; Part II: Participants in Follow-Up; To be eligible to participate in Part II of this study, an individual must meet all of the following criteria:
- HPV16 biomarker detected in Part I screen
- Willingness to complete annual follow-up visits
Who cannot take part
- Presence of medical or psychiatric condition affecting ability to give voluntary, informed consent
- History of head and neck cancer; Part II: Participants in Follow-Up; An individual who meets any of the following criteria will be excluded from participation in this part of the study:
- Part I: Participants in Screening; An individual who meets any of the following criteria will be excluded from participation in this study:
- Participants who do not speak English cannot enroll because the consent and study survey are only available in English. However, if there is a hearing, literacy, or minor fluency issue and the participant requests assistance from a family member or the study coordinator, this individual may still enroll and receive this assistance to ensure the participant fully hears and understands everything being asked
- Unable to complete annual follow-up visits
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 40 and 69 years old?
Where in United States
- Johns Hopkins HospitalBaltimore, United StatesContact: Amber D'Souza, PhDNot yet recruiting
About the trial
What the trial wants to find out
This study will screen people for biomarkers of Human Papillomavirus (HPV) to form a cohort of people who may be at increased risk of HPV-oropharyngeal cancer (HPV-OPC). The investigators will follow these individuals prospectively to evaluate risk for OPC.
The group in the trial
- Prospective Observational Cohort
Prospective cohort of adult male participants from two groups: community group (see eligibility form) an biobank group (enrolled from MWCCS cohort). Both groups will undergo initial screening, with eligible participants continuing onto follow-up testing, which may include blood collection, oral rinse collection, anal Pap smear, ultrasound imaging, and surveys.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- SORT (Screening fOR Throat Cancer)
- Criteria questions
- Built from NCT07940751, who can take part
- Record updated
- 17 November 2026